HIV

The AJMC® HIV compendium is a comprehensive resource for clinical news and expert insights for the condition, including disparities in care, prevention of infection among at-risk groups, and the importance of viral suppression.

Latest News

Image credit: Yale School of Medicine
Lenacapavir Offers Promising Step Forward in HIV Prevention: Q&A With Onyema Ogbuagu, MBBCh, FACP, FIDSA

June 19th 2025

The approval of lenacapavir for use as pre-exposure prophylaxis is a significant step in reducing the incidence of HIV across the globe, including in areas where the PURPOSE trials were conducted.

FDA Approved
Twice-Yearly Lenacapavir Approval Marks Major Milestone in Prevention of HIV

June 18th 2025

Zandraetta Tims-Cook
Contributor: PrEP in Practice – How to Start Conversations About HIV Prevention

June 17th 2025

Vaccine | Image credit: weyo - stock.adobe.com
Cuts to HIV Vaccine Research Come Amid Challenges to Other Vaccines, Treatment

June 13th 2025

Doctor communicating with patient | Image credit: bongkarn - stock.adobe.com
People Living With HIV Communicate Less With Health Care Providers

June 9th 2025

Clarifying USPSTF Recommendations for HIV Pre-Exposure Prophylaxis (PrEP)

This discussion focuses on how to address barriers and disparities as obstacles to using PrEP, with a focus on USPSTF PrEP guidelines and ACA Part 47 for payers and providers.

This multi-stakeholder roundtable panel discussion will focus on how to address barriers and disparities as obstacles to the use of PrEP, with a focus on increased understanding and education around US Preventive Services Task Force (USPSTF) PrEP guidelines and Affordable Care Act Part 47 for payers and providers.
Continuing Medical Education
View All
June 20th 2025

Navigating the HIV Treatment Frontier: Equipping Managed Care Professionals With Strategies for Innovation, Access, and Adherence

1.5 Credits / HIV/AIDS, Infectious Diseases

More News

This Week in Managed Care: March 22, 2019
March 22nd 2019

This Week in Managed Care: March 22, 2019

This week, the top managed care news included new primary prevention guidelines that could increase the use of some diabetes drugs; the FDA expanded criteria for which patients can take part in clinical trials; a summit on value-based insurance design showed the need for tough conversations with stakeholders.
CDC Says New HIV Transmissions Stem From Lack of Treatment, Unawareness of Infection
March 20th 2019

CDC Says New HIV Transmissions Stem From Lack of Treatment, Unawareness of Infection

Wallace Stephens
The majority of new HIV infections have been found to be transmitted by individuals who are unaware that they have HIV or by those who know they have HIV but are not receiving treatment to suppress their infection.
Participation in Community Groups Found to Increase Awareness of PrEP
March 16th 2019

Participation in Community Groups Found to Increase Awareness of PrEP

Wallace Stephens
Gay or bisexual men who participated in community groups were found have a higher awareness of pre-exposure prophylaxis (PrEP) than those who did not. PrEP has proven to be a successful preventive measure to decrease the spread of HIV.
Proposed 2020 White House Budget Includes Block Grants, Medicaid Work Rules, Increased HIV Funding
March 12th 2019

Proposed 2020 White House Budget Includes Block Grants, Medicaid Work Rules, Increased HIV Funding

Jaime Rosenberg Allison Inserro
The president has released his budget for fiscal year (FY) 2020, which calls for converting Medicaid to a system of block grants and requiring all able-bodied Medicaid recipients to hold a job or perform community service. The $87.1 billion allocated to HHS, a 12% cut, would include increases to federal HIV funding, but drops in global funding, as well as cuts to the National Institutes of Health (NIH).
Dr Paul Sax Outlines Effective Treatments for Multidrug-Resistant HIV
March 9th 2019

Dr Paul Sax Outlines Effective Treatments for Multidrug-Resistant HIV

Most patients with multidrug-resistant HIV can still be treated with existing therapies, explained Paul Sax, MD, clinical director of the Division of Infectious Diseases at Brigham and Women's Hospital and professor of medicine at Harvard University.
This Week in Managed Care: March 8, 2019
March 8th 2019

This Week in Managed Care: March 8, 2019

This week, the top managed care news included Scott Gottlieb, MD, resigning as FDA commissioner; Eli Lilly offering a discounted version of Humalog; and a second patient reported cured of HIV.
Is There a Future for Effective Vaccines for Infectious Diseases?
March 8th 2019

Is There a Future for Effective Vaccines for Infectious Diseases?

Jaime Rosenberg
This is part 1 of a 3-part vaccine series covering the potential of vaccines for infectious diseases, the impact of the antivaccination movement, and the promise of vaccines for cancer treatment.
What We're Reading: HIV Cured in Second Patient; Patients Question FDA; China Creating Ethics Committee
March 5th 2019

What We're Reading: HIV Cured in Second Patient; Patients Question FDA; China Creating Ethics Committee

AJMC Staff
A second patient has been reported to have been cured of infection with HIV since the start of the epidemic; thousands have reported complications to the FDA with medical devices and implants; a 30-person national ethics committee has been appointed in China to oversee high-risk clinical trials.
Estimating the Cost-Effectiveness of PrEP Over 40 Years
March 2nd 2019

Estimating the Cost-Effectiveness of PrEP Over 40 Years

Wallace Stephens
Short-term investments pertaining to the distribution of PrEP are expected to result in long-term cost-savings and promote significant health benefits following its introduction in Germany, according to a new modelling study.
HIV, Hepatitis C Drugs Continue to Be Most Costly Group of Outpatient Drugs for Medicaid
February 28th 2019

HIV, Hepatitis C Drugs Continue to Be Most Costly Group of Outpatient Drugs for Medicaid

Jaime Rosenberg
Between 2014 and 2017, antivirals were consistently the number 1 most costly outpatient drug group for Medicaid, and HIV antiretrovirals and hepatitis C drugs accounted for more than 90% of spending on these antivirals.
Dr W. David Hardy: Efforts Needed for President Trump's Plan to End HIV Epidemic in 10 Years
February 20th 2019

Dr W. David Hardy: Efforts Needed for President Trump's Plan to End HIV Epidemic in 10 Years

W. David Hardy, MD, adjunct professor of medicine, Johns Hopkins University, discusses the importance of identifying patients with undiagnosed HIV and preventing new infections for accomplishing President Trump's plan to end the HIV epidemic in 10 years.
What We're Reading: Young Blood Injections; Gilead Accused of Kickbacks; Minor Consent for PrEP
February 20th 2019

What We're Reading: Young Blood Injections; Gilead Accused of Kickbacks; Minor Consent for PrEP

AJMC Staff
The FDA is warning against services offering to inject older adults with younger people's blood plasma; Gilead is being accused of providing kickbacks to providers to boost sales of its drugs; and a bill in Maryland would allow minors to consent to preventive treatment for HIV.
What We're Reading: Kaiser Permanente's Tuition Offer; Menopause and the Brain; Air Force and HIV
February 19th 2019

What We're Reading: Kaiser Permanente's Tuition Offer; Menopause and the Brain; Air Force and HIV

AJMC Staff
Kaiser Permanente will waive annual tuition for the first 5 classes of its new medical school, following a similar move by the New York University School of Medicine; menopause is typically thought of in terms of the end of fertility, but more attention is being paid to the effects of the lack of estrogen on the brain; a federal judge has ordered the US Air Force to temporarily stop discharging service members who are HIV-positive.
Diagnosis and Treatment of Cognitive Impairment in HIV Patients
February 19th 2019

Diagnosis and Treatment of Cognitive Impairment in HIV Patients

Wallace Stephens
As survival rates for people living with HIV continue to increase and the population grows older, cognitive impairment is becoming more common.
Study Will Follow Outcomes of HIV-to-HIV Liver Transplants
February 14th 2019

Study Will Follow Outcomes of HIV-to-HIV Liver Transplants

Jaime Rosenberg
The HOPE in Action Multicenter Liver Study will determine the safety of 80 HIV-to-HIV liver transplants.
Immunotherapy Is Safe, Effective in Patients With Cancer Living With HIV
February 12th 2019

Immunotherapy Is Safe, Effective in Patients With Cancer Living With HIV

Jaime Rosenberg
A systematic review has found that immune checkpoint inhibitors are safe in patients with cancer living with HIV, and that these patients have similar objective response rates for certain cancers that have been seen in uninfected patients with cancer.
Podcast: This Week in Managed Care—State of the Union Health Initiatives and Other Health News
February 10th 2019

Podcast: This Week in Managed Care—State of the Union Health Initiatives and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.
This Week in Managed Care: February 8, 2019
February 8th 2019

This Week in Managed Care: February 8, 2019

This week, the top managed care news included President Trump's State of the Union address highlighting healthcare; HHS Secretary Alex Azar taking on drug rebates; and physicians asking Congress to fully implement the HITECH Act.
HIV Experts Across HHS Outline Plan for Ending HIV Epidemic Within 10 Years
February 7th 2019

HIV Experts Across HHS Outline Plan for Ending HIV Epidemic Within 10 Years

Jaime Rosenberg
Following President Trump’s second State of the Union address, where he announced plans to end the HIV epidemic, HIV experts from across HHS outlined a comprehensive plan of action focusing on diagnosis, treatment, prevention, and response.
Trump Highlights New Initiatives for Childhood Cancer, HIV in State of the Union
February 6th 2019

Trump Highlights New Initiatives for Childhood Cancer, HIV in State of the Union

Laura Joszt, MA
During his second State of the Union address, President Trump highlighted past bipartisan accomplishments, such as legislation to confront the opioid crisis, but also outlined future priorities, such as addressing the cost of healthcare and prescription drugs.
What We're Reading: Trump May Include HIV Plan in Speech; Judge Tosses ACA Suit; CF Treatment Gaps
February 4th 2019

What We're Reading: Trump May Include HIV Plan in Speech; Judge Tosses ACA Suit; CF Treatment Gaps

AJMC Staff
While President Trump's State of the Union address is not finalized, he may plan to unveil a promise to end HIV transmission in America by 2030; a federal judge dismissed a lawsuit brought by Maryland that claimed the Trump administration is failing to enforce the Affordable Care Act; new cystic fibrosis (CF) treatments targeting the genetic mutations that cause the disease help about 90% of patients, meaning that 10% are still waiting for a cutting-edge therapy.
ACC/AHA Cholesterol Guidelines Increased Statin Eligibility for Patients With HIV, But Challenges Persist
February 2nd 2019

ACC/AHA Cholesterol Guidelines Increased Statin Eligibility for Patients With HIV, But Challenges Persist

Jaime Rosenberg
When the American College of Cardiology/American Heart Association (ACC/AHA) released new cholesterol guidelines in 2013, replacing older guidelines and changing statin eligibility, more patients with HIV became recommended for statin therapy. However, many patients are still not recommended for or prescribed the treatment.
Researchers Say They Can Now Accurately Measure HIV Reservoirs
January 30th 2019

Researchers Say They Can Now Accurately Measure HIV Reservoirs

Jaime Rosenberg
Being able to accurately measure HIV reservoirs that remain in the body even during viral suppression is the first step to being able to destroy these reservoirs and, potentially, cure the infection. Researchers say they've created a new technique that will allow them to do so.
Lung Disease From Smoking Marijuana More Likely in Men With HIV
January 26th 2019

Lung Disease From Smoking Marijuana More Likely in Men With HIV

Jaime Rosenberg
Men living with HIV are more likely to develop lung disease from long-term marijuana smoking compared with uninfected men.
HIV, Vaccine Refusal, Delays Among Greatest Threats to Global Health, Says WHO
January 22nd 2019

HIV, Vaccine Refusal, Delays Among Greatest Threats to Global Health, Says WHO

Jaime Rosenberg
The organization's list of 10 health challenges include both environmental and medical challenges they say demand attention from the World Health Organization (WHO) and health partners in 2019.
NIH Researchers Say the Science Is Clear: Undetectable Equals Untransmittable in HIV
January 16th 2019

NIH Researchers Say the Science Is Clear: Undetectable Equals Untransmittable in HIV

Jaime Rosenberg
Researchers from the National Institutes of Health (NIH)’s National Institute of Allergy and Infectious Diseases reviewed clinical trials and cohort studies validating the concept that people living with HIV who have achieved viral suppression can not sexually transmit HIV.
Damaged Immune Receptor Could Lead to More Severe Comorbidities in HIV, Study Finds
January 14th 2019

Damaged Immune Receptor Could Lead to More Severe Comorbidities in HIV, Study Finds

Samantha DiGrande
While treatment for HIV has made tremendous strides over the past few decades, many patients with the infection still struggle with comorbidities such as chronic inflammation, diabetes, and cardiovascular problems, among others. In a recent study, researchers at Michigan State University sought to understand why patients with HIV develop such complications.
Following Discrimination Allegations, Insurer Will Stop Denying Coverage Based on PrEP Usage
January 11th 2019

Following Discrimination Allegations, Insurer Will Stop Denying Coverage Based on PrEP Usage

Jaime Rosenberg
Mutual of Omaha has agreed to no longer deny life insurance and long-term insurance to people using Truvada for HIV prevention following allegations of discrimination in 2 separate settlements.
State Data Show Racial/Ethnic Disparities in HIV, Syphilis Diagnoses Among MSM
January 8th 2019

State Data Show Racial/Ethnic Disparities in HIV, Syphilis Diagnoses Among MSM

Jaime Rosenberg
Using state-level surveillance data of reported HIV and syphilis cases among men who have sex with men (MSM), researchers found a widely disparate impact of HIV and syphilis among black and Hispanic MSM compared with white MSM.
People Living With HIV Have 2-Fold Risk of Heart Failure
January 5th 2019

People Living With HIV Have 2-Fold Risk of Heart Failure

Jaime Rosenberg
People living with HIV are at a greater risk for incident heart failure, with those with higher viral loads and lower CD4+ T cell counts having the greatest risk.
<1
...
192021222324252627
...
32>

2 Commerce Drive
Suite 100
Cranbury, NJ 08512

© 2025 MJH Life Sciences® and AJMC®.
All rights reserved.

About
Contact
Editorial Boards
Advertise
Do Not Sell My Information
Terms & Conditions
Privacy Policy
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo